These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620 [TBL] [Abstract][Full Text] [Related]
3. Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels. Sauvageau S; Thorin E; Villeneuve L; Dupuis J Pulm Pharmacol Ther; 2009 Aug; 22(4):311-7. PubMed ID: 19489130 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027 [TBL] [Abstract][Full Text] [Related]
5. The endothelin system in pulmonary arterial hypertension. Galié N; Manes A; Branzi A Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539 [TBL] [Abstract][Full Text] [Related]
6. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension. Yu J; Taylor L; Wilson J; Comhair S; Erzurum S; Polgar P J Cell Physiol; 2013 Feb; 228(2):322-9. PubMed ID: 22688668 [TBL] [Abstract][Full Text] [Related]
7. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats. Nishida M; Okada Y; Akiyoshi K; Eshiro K; Takoaka M; Gariepy CE; Yanagisawa M; Matsumura Y Eur J Pharmacol; 2004 Aug; 496(1-3):159-65. PubMed ID: 15359489 [TBL] [Abstract][Full Text] [Related]
8. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988 [TBL] [Abstract][Full Text] [Related]
9. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice. Akashi K; Saegusa J; Sendo S; Nishimura K; Okano T; Yagi K; Yanagisawa M; Emoto N; Morinobu A Arthritis Res Ther; 2016 May; 18(1):113. PubMed ID: 27209208 [TBL] [Abstract][Full Text] [Related]
10. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension. Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299 [TBL] [Abstract][Full Text] [Related]
11. Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Ivy DD; Le Cras TD; Horan MP; Abman SH Am J Physiol; 1998 Apr; 274(4):L535-41. PubMed ID: 9575871 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528 [TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonists as disease modifiers in systemic sclerosis. Shetty N; Derk CT Inflamm Allergy Drug Targets; 2011 Feb; 10(1):19-26. PubMed ID: 21184655 [TBL] [Abstract][Full Text] [Related]
15. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction. Holm P Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559 [TBL] [Abstract][Full Text] [Related]
16. Distortion of K Angus JA; Hughes RJA; Wright CE Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226623 [TBL] [Abstract][Full Text] [Related]
17. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade. Jasmin JF; Cernacek P; Dupuis J Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096 [TBL] [Abstract][Full Text] [Related]
18. Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension. Iannone F; Riccardi MT; Guiducci S; Bizzoca R; Cinelli M; Matucci-Cerinic M; Lapadula G Ann Rheum Dis; 2008 Aug; 67(8):1121-6. PubMed ID: 18029384 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism. Juergens UR; Racké K; Uen S; Haag S; Lamyel F; Stöber M; Gillissen A; Novak N; Vetter H Pulm Pharmacol Ther; 2008; 21(3):533-9. PubMed ID: 18295521 [TBL] [Abstract][Full Text] [Related]
20. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model. Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]